DAOBOOST

Serial Number 98302132
688

Registration Progress

Application Filed
Dec 6, 2023
Under Examination
Jul 8, 2025
Approved for Publication
May 13, 2025
Published for Opposition
May 13, 2025
Registered

Attorney Assistance

NOA E-Mailed - SOU Required
Due: Jan 08, 2026 167 days

Trademark Image

DAOBOOST

Basic Information

Serial Number
98302132
Filing Date
December 6, 2023
Published for Opposition
May 13, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
688
Status Date
Jul 8, 2025
Application
Pending
Classes
005

Rights Holder

STADA Arzneimittel AG

03
Address
Stadastraße 2-18
Bad Vilbel 61118
DE

Ownership History

STADA Arzneimittel AG

Original Applicant
03
Bad Vilbel DE

STADA Arzneimittel AG

Owner at Publication
03
Bad Vilbel DE

Legal Representation

Attorney
Charles T. J. Weigell

USPTO Deadlines

Next Deadline
167 days remaining
NOA E-Mailed - SOU Required
Due Date
January 08, 2026
Extension Available
Until July 08, 2026

Application History

14 events
Date Code Type Description Documents
Jul 8, 2025 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
May 13, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
May 13, 2025 PUBO A PUBLISHED FOR OPPOSITION Loading...
May 7, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Apr 14, 2025 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Sep 6, 2024 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Sep 6, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Sep 6, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jun 25, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Jun 25, 2024 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jun 25, 2024 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jun 25, 2024 GNRT F NON-FINAL ACTION E-MAILED Loading...
Mar 4, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Dec 6, 2023 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of Histamine Intolerance containing diamine oxidase enzymes; chemico-pharmaceutical pharmaceutical preparations for the treatment of Histamine Intolerance, containing diamine oxidase enzymes; sanitary preparations for medical purposes featuring diamine oxidase enzymes; biological preparations for medical purposes, namely, for the treatment of Histamine Intolerance, containing diamine oxidase enzymes; chemical preparations for medical purposes, namely, for the treatment of Histamine Intolerance, containing diamine oxidase enzymes; diamine oxidase enzymes and diamine oxidase enzyme preparations for medical purposes; dietetic foods adapted for medical purposes containing diamine oxidase enzymes; diagnostic preparations for medical purposes containing diamine oxidase enzymes; chemical reagents for medical purposes containing diamine oxidase enzymes; nutritional additives for medical purposes for use in foods and dietary supplements for human consumption, containing diamine oxidase enzymes; nutritional additives to foodstuffs for animals for medical purposes containing diamine oxidase enzymes

Classification

International Classes
005